Detalhe da pesquisa
1.
Effects of Jak2 type 1 inhibitors NVP-BSK805 and NVP-BVB808 on Jak2 mutation-positive and Bcr-Abl-positive cell lines.
Acta Haematol;
132(1): 75-86, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24504330
2.
Low-Dose Interleukin-2 Therapy: Fine-tuning Treg in Solid Organ Transplantation?
Transplantation;
2024 Jan 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38294829
3.
Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS).
Blood;
116(19): 3758-65, 2010 Nov 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20679528
4.
High prevalence of hemoglobin disorders and glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Republic of Guinea (West Africa).
Hemoglobin;
36(1): 25-37, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21929367
5.
Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective.
Front Cell Dev Biol;
10: 1081644, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36794233
6.
Advanced Therapy Medicinal Products' Translation in Europe: A Developers' Perspective.
Front Med (Lausanne);
9: 757647, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35186986
7.
Longitudinal Study to Assess the Clinical Significance of MSI2 Expression in Chronic Myeloid Leukemia Patients.
Acta Haematol;
136(1): 62-4, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27160312
8.
European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor.
Blood;
112(12): 4437-44, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18716134
9.
Single-cell analysis based dissection of clonality in myelofibrosis.
Nat Commun;
11(1): 73, 2020 01 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31911629
10.
How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet.
Haematologica;
94(8): 1135-50, 2009 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19586938
11.
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
N Engl J Med;
349(15): 1423-32, 2003 Oct 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14534335
12.
Detection of Wilms' tumor antigen--specific CTL in tumor-draining lymph nodes of patients with early breast cancer.
Clin Cancer Res;
12(1): 34-42, 2006 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16397021
13.
GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome.
Exp Hematol;
44(7): 590-595.e1, 2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27080012
14.
BCL-6: rearrangement and mutation in lymphoma.
Methods Mol Med;
115: 251-70, 2005.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15998973
15.
Up-regulated MSI2 is associated with more aggressive chronic myeloid leukemia.
Leuk Lymphoma;
56(7): 2105-13, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25363400
16.
Human cytotoxic T lymphocytes specific for Wilms' tumor antigen-1 inhibit engraftment of leukemia-initiating stem cells in non-obese diabetic-severe combined immunodeficient recipients.
Transplantation;
75(9): 1429-36, 2003 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12792492
17.
Expression patterns of WT-1 and Bcr-Abl measured by TaqMan quantitative real-time RT-PCR during follow-up of leukemia patients with the Ph chromosome.
Chin Med J (Engl);
117(7): 968-71, 2004 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15265366
18.
JAK2 V617F allele burden quantified by real time quantitative polymerase chain reaction and competitive polymerase chain reaction in patients with chronic myeloproliferative neoplasia.
Leuk Lymphoma;
55(1): 128-35, 2014 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23607255
19.
BCR-ABL transcript dynamics support the hypothesis that leukemic stem cells are reduced during imatinib treatment.
Clin Cancer Res;
17(21): 6812-21, 2011 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21903771
20.
Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
Rev Bras Hematol Hemoter;
37(2): 142-3, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25818829